Owll Translator App Introduces AI Voice Cloning to Personalize Voice Translations in Over 100 Languages
Speak Naturally—In Any Language
Owll Translator's update adds true voice cloning, allowing users to easily translate and 'speak' naturally in over 100 languages while retaining their unique vocal pitch, timbre, and even emotional expression—made possible with a short 10-60 seconds recording of users' speech. Say goodbye to robotic, choppy translations and communicate authentically across language barriers.
Real-Time Translation, Simplified
The updated app now also delivers instant audio playback, seamless voice input, and clearer text display. Users can speak naturally without interruptions or distractions, as the app takes care of everything in real time.
Designed for Real Conversations
Owll Translator is built for practical, high-stakes communication—it provides fast conference interpretation that keeps up with live conversations, manages multiple speakers in group chats clearly, and automatically summarizes long meetings into concise notes with key tasks.
The app also ensures industry-specific accuracy with built-in specialized vocabularies and expert-verified terminology for medical, legal, and religious contexts; and supports more than 100 languages and dialects, including regional variations.
Owll Translator was previously known as Deeptran, and was recently rebranded to align the app with Owll , an AI note-taking app also developed by Vocalbeats.AI. This move reflects a focused product strategy to unify the company's real-time productivity tools under a more cohesive and searchable naming system—making it easier for users to discover and connect with Vocalbeats.AI's suite of AI solutions.
Now Available on the App Store
Owll Translator is now available on the Apple App Store . Existing users of Deeptran will automatically receive the update, including the new name and feature set.
About Vocalbeats
Vocalbeats is dedicated to building the world's largest audio platforms to better connect and communicate while pioneering innovation in AI-powered products and experiences. The company fosters a globally diverse and inclusive team, committed to revolutionizing audio platforms by leveraging the synergy of heterogenous perspectives. This commitment ensures the creation of innovative products that resonate worldwide.
The company has a dedicated artificial intelligence division, dubbed Vocalbeats.AI, which focuses on building intelligent, user-friendly products and services to improve everyday life through advanced AI that is more accessible, intuitive and human.
For more information, please visit www.vocalbeats.com .
Media contact: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of GSK plc ('GSK' or the 'Company') (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 17, 2025, GSK issued a press release announcing 'that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of Blenrep (belantamab mafodotin-blmf) combinations.' On this news, GSK's American Depositary Receipt ('ADR') price fell $1.81 per share, or 4.73%, to close at $36.47 per share on July 17, 2025. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See . Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle PeytonPomerantz LLP [email protected] 646-581-9980 ext. 7980
Business Upturn
an hour ago
- Business Upturn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc.
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ('Ultragenyx' or the 'Company') (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On July 9, 2025, Ultragenyx and its development partner Mereo BioPharma Group plc issued a press release 'announc[ing] that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis[.]' Following a Data Monitoring Committee meeting, the two companies advised that the final analysis would occur 'around the end of the year.' On this news, Ultragenyx's stock price fell $10.41 per share, or 25.11%, to close at $31.04 per share on July 10, 2025. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See . Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Danielle PeytonPomerantz LLP [email protected] 646-581-9980 ext. 7980
Business Upturn
an hour ago
- Business Upturn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc.
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. ('KBR' or the 'Company') (NYSE: KBR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether KBR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 20, 2025, KBR issued a press release announcing that 'HomeSafe Alliance, a KBR . . . Joint Venture, informed us on June 18, 2025, that U.S. Transportation Command (TRANSCOM) has terminated HomeSafe's role in the Global Household Goods Contract, a contract designed to improve the moving system for military service members and their families.' On this news, KBR's stock price fell $3.85 per share, or 7.29%, to close at $48.93 per share on June 20, 2025. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLP [email protected] 646-581-9980 ext. 7980
